Tomas Baka

Bratislava, BL 81108, Slovakia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Protection against isoproterenol-induced cardiac injury by sacubitril/valsartan is associated with upregulation of the alternative renin-angiotensin-aldosterone system pathway.

Protection against isoproterenol-induced cardiac injury by sacubitril/valsartan is associated with upregulation of the alternative renin-angiotensin-aldosterone system pathway.

Journal: Scientific reports

Published: December 09, 2025

Effect of Sacubitril/Valsartan, Ivabradine, and Captopril on Anxiety-like Behavior in Spontaneously Hypertensive Rats.

Effect of Sacubitril/Valsartan, Ivabradine, and Captopril on Anxiety-like Behavior in Spontaneously Hypertensive Rats.

Journal: International journal of molecular sciences

Published: October 06, 2025

Biological Indicators of Cardiovascular Health by Foster Care History in Adults.

Biological Indicators of Cardiovascular Health by Foster Care History in Adults.

Journal: American journal of preventive medicine

Published: February 12, 2025

Empagliflozin enhances metabolic efficiency and improves left ventricular hypertrophy in a hypertrophic cardiomyopathy mouse model.

Empagliflozin enhances metabolic efficiency and improves left ventricular hypertrophy in a hypertrophic cardiomyopathy mouse model.

Journal: European heart journal

Published: June 25, 2024

Considering chronotype to improve hypertension management.

Considering chronotype to improve hypertension management.

Journal: EClinicalMedicine

Published: June 15, 2024

SGLT2 inhibitor upregulates myocardial genes for oxidative phosphorylation and fatty acid metabolism in Gαq-mice.

SGLT2 inhibitor upregulates myocardial genes for oxidative phosphorylation and fatty acid metabolism in Gαq-mice.

Journal: Journal of molecular and cellular cardiology plus

Published: June 10, 2024

Pharmacological stimulation of the parasympathetic system - a promising means of cardioprotection in heart failure.

Pharmacological stimulation of the parasympathetic system - a promising means of cardioprotection in heart failure.

Journal: Hypertension research : official journal of the Japanese Society of Hypertension

Published: March 26, 2024

Sacubitril/Valsartan Alleviates Cardiac Remodeling and Dysfunction in L-NAME-Induced Hypertension and Hypertensive Heart Disease.

Sacubitril/Valsartan Alleviates Cardiac Remodeling and Dysfunction in L-NAME-Induced Hypertension and Hypertensive Heart Disease.

Journal: Biomedicines

Published: February 15, 2024

Effect of sacubitril/valsartan on the hypertensive heart in continuous light-induced and lactacystin-induced pre-hypertension: Interactions with the renin-angiotensin-aldosterone system.

Effect of sacubitril/valsartan on the hypertensive heart in continuous light-induced and lactacystin-induced pre-hypertension: Interactions with the renin-angiotensin-aldosterone system.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 11, 2023

The effect of zofenopril on the cardiovascular system of spontaneously hypertensive rats treated with the ACE2 inhibitor MLN-4760.

The effect of zofenopril on the cardiovascular system of spontaneously hypertensive rats treated with the ACE2 inhibitor MLN-4760.

Journal: Biological research

Published: April 18, 2023

SGLT2 inhibitor ertugliflozin decreases elevated intracellular sodium, and improves energetics and contractile function in diabetic cardiomyopathy.

SGLT2 inhibitor ertugliflozin decreases elevated intracellular sodium, and improves energetics and contractile function in diabetic cardiomyopathy.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 06, 2022

Melatonin as a Potential Approach to Anxiety Treatment.

Melatonin as a Potential Approach to Anxiety Treatment.

Journal: International journal of molecular sciences

Published: November 15, 2022

Showing 1-12 of 41

Last Updated: 09/26/2026